Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Autophagy Selective Therapeutics (COAST) in Advanced Solid Tumors or Relapsed Prostate Cancer, A Phase I/II Trial

NCT05036226 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT05036226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05036226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Autophagy Selective Therapeutics (COAST) in Advanced Solid Tumors or Relapsed Prostate Cancer, A Phase I/II Trial
Lead sponsor
Medical University of South Carolina
Phase
Phase 1/2
Overall status
Recruiting
Start date
March 3, 2022
Completion date
May 21, 2028
Enrollment
76 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer recurrent, solid tumor, adult